Dosage recommendations for remimazolam should consider the possibility of delirium as a side effect
Crossref DOI link: https://doi.org/10.1007/s12630-024-02822-1
Published Online: 2024-08-12
Published Print: 2024-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yarımoğlu, Rafet https://orcid.org/0000-0002-1189-8448
Basaran, Betul
Text and Data Mining valid from 2024-08-12
Version of Record valid from 2024-08-12
Article History
Received: 29 February 2024
Revised: 15 March 2024
Accepted: 28 March 2024
First Online: 12 August 2024